ArticleOncotarget2018

KIR2DL2 combined with HLA-C1 confers risk of hepatitis C virus-related hepatocellular carcinoma in younger patients.

Hiromi Saito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.